XML 34 R20.htm IDEA: XBRL DOCUMENT v3.20.1
COVID-19 Impacts (Notes)
3 Months Ended
Mar. 31, 2020
Covid-19 Impacts [Abstract]  
Covid-19 [Abstract]
COVID-19 Impacts
In March 2020, the World Health Organization categorized COVID-19 as a global pandemic. Subsequent to March 31, 2020, the United States, and the global regions where the Company operates, continue to be impacted by COVID-19. Around the world, local governments’ responses to COVID-19 continue to evolve, which has led to stay-at-home orders and social distancing guidelines that have disrupted various industries in the global economy.
During this pandemic, the Company has implemented additional guidelines to further protect the health and safety of its employees as the Company continues to operate with its suppliers and customers. The Company has committed to maintaining a paramount focus on the safety of its employees while minimizing potential disruptions caused by COVID-19. For example, the Company is following all legislatively-mandated travel directives in the various countries where it operates, and the Company has also put additional travel restrictions in place for its associates designed to reduce the risk from COVID-19. Additionally, the Company is utilizing extended work from home options to protect its office associates, while adjusting its meeting protocols and processes at its manufacturing sites.
The Company’s businesses have been designated by many governments as essential businesses as of March 31, 2020 and the vast majority of the Company’s operations are continuing. The Company is closely monitoring the impact of the COVID-19 pandemic on all aspects of its businesses and geographies, including the impact on its facilities, employees, customers, suppliers, vendors, business partners and distribution. While the Company did not incur significant adverse financial impacts or business disruptions during the three months ended March 31, 2020 from COVID-19, it is unable to predict the impact that COVID-19 will have on its future financial position, operating results or cash flows due to numerous uncertainties, including new information which may emerge concerning the severity and duration of COVID-19 and the actions to contain the virus or treat its impact, among others.